Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Schenck

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Drug Development and Industrial Pharmacy|January 5, 2019
Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material propertiesLuke Schenck, Athanas Koynov, Aaron Cote
Molecular Pharmaceutics|August 19, 2022
Dissolution Behavior of Weakly Basic Pharmaceuticals from Amorphous Dispersions Stabilized by a Poly(dimethylaminoethyl Methacrylate) CopolymerDerek S Frank, Prateek Prasad, Luca Iuzzolino, et al.
Journal of Pharmaceutical Sciences|May 9, 2023
Templated Reactive Crystallization of Active Pharmaceutical Ingredient in Hydrogel Microparticles Enabling Robust Drug Product ProcessingPurnima N Manghnani, Luke Schenck, Saif A Khan, et al.
Pharmaceutics|December 28, 2021
Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of PosaconazoleDerek Frank, Luke Schenck, Athanas Koynov, et al.
Pharmaceutical Research|October 22, 2022
Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder PropertiesDerek S Frank, Ashish Punia, Mairead Fahy, et al.
Pharmaceutics|August 10, 2021
Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo StudiesLuke Schenck, Christopher Boyce, Derek Frank, et al.
Journal of Pharmaceutical Sciences|December 8, 2023
A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical IndustryLuke Schenck, Bailey Risteen, Lindsay Michelle Johnson, et al.
Pharmaceutics|September 23, 2022
Varied Bulk Powder Properties of Micro-Sized API within Size Specifications as a Result of Particle Engineering MethodsZijian Wang, Marina Solomos, Stephanus Axnanda, et al.
Journal of Pharmaceutical Sciences|June 5, 2021
A Co-Processed API Approach for a Shear Sensitive Compound Affording Improved Chemical Stability and Streamlined Drug Product ProcessingLuke Schenck, Claudia Neri, Xiujuan Jia, et al.
Molecular Pharmaceutics|January 31, 2023
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid DispersionsKristen N Kelsall, Leila M Foroughi, Derek S Frank, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Drug Development and Industrial Pharmacy|January 5, 2019
Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material propertiesLuke Schenck, Athanas Koynov, Aaron Cote
Molecular Pharmaceutics|August 19, 2022
Dissolution Behavior of Weakly Basic Pharmaceuticals from Amorphous Dispersions Stabilized by a Poly(dimethylaminoethyl Methacrylate) CopolymerDerek S Frank, Prateek Prasad, Luca Iuzzolino, et al.
Journal of Pharmaceutical Sciences|May 9, 2023
Templated Reactive Crystallization of Active Pharmaceutical Ingredient in Hydrogel Microparticles Enabling Robust Drug Product ProcessingPurnima N Manghnani, Luke Schenck, Saif A Khan, et al.
Pharmaceutics|December 28, 2021
Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of PosaconazoleDerek Frank, Luke Schenck, Athanas Koynov, et al.
Pharmaceutical Research|October 22, 2022
Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder PropertiesDerek S Frank, Ashish Punia, Mairead Fahy, et al.
Pharmaceutics|August 10, 2021
Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo StudiesLuke Schenck, Christopher Boyce, Derek Frank, et al.
Journal of Pharmaceutical Sciences|December 8, 2023
A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical IndustryLuke Schenck, Bailey Risteen, Lindsay Michelle Johnson, et al.
Pharmaceutics|September 23, 2022
Varied Bulk Powder Properties of Micro-Sized API within Size Specifications as a Result of Particle Engineering MethodsZijian Wang, Marina Solomos, Stephanus Axnanda, et al.
Journal of Pharmaceutical Sciences|June 5, 2021
A Co-Processed API Approach for a Shear Sensitive Compound Affording Improved Chemical Stability and Streamlined Drug Product ProcessingLuke Schenck, Claudia Neri, Xiujuan Jia, et al.
Molecular Pharmaceutics|January 31, 2023
Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid DispersionsKristen N Kelsall, Leila M Foroughi, Derek S Frank, et al.
Pageof 3